Fingolimod extension study

Results after four and half years show that people who started in the beta interferon arm had fewer relapses and less MRI activity after they had switched to fingolimod. MS News Today Disease modifying drugs for relapsing remitting MS
Source: Multiple Sclerosis Trust - Category: Neurology Source Type: news